复旦复华(600624) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥157,444,561.42, a decrease of 5.86% compared to the same period last year[2] - The net profit attributable to shareholders was -¥16,445,964.90, representing a decline of 398.32% year-over-year[2] - Total operating revenue for the first three quarters of 2024 was CNY 476,767,356.22, a decrease of 7.8% compared to CNY 517,462,135.52 in the same period of 2023[15] - Net profit for the third quarter of 2024 was a loss of CNY 33,596,764.78, compared to a profit of CNY 7,662,536.64 in the same quarter of 2023[17] - The net profit attributable to the parent company for Q3 2024 was -32,208,610.08 RMB, compared to a profit of 6,912,425.81 RMB in Q3 2023, indicating a significant decline[18] - Total comprehensive income for Q3 2024 was -33,687,697.99 RMB, compared to -1,457,448.73 RMB in the same period last year[18] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date was -¥46,399,026.05, a decrease of 585.86% compared to the previous year[3] - Cash flow from operating activities for the first three quarters of 2024 was 537,086,480.49 RMB, down from 618,769,577.18 RMB in the first three quarters of 2023, representing a decrease of approximately 13.14%[19] - The net cash flow from operating activities for the first three quarters of 2024 was -46,399,026.05 RMB, contrasting with a positive cash flow of 9,549,845.68 RMB in the same period of 2023[19] - The company reported a significant decrease in cash and cash equivalents from 305.48 million RMB to 126.22 million RMB, a drop of approximately 58.7%[13] - Cash and cash equivalents at the end of Q3 2024 were 125,143,358.06 RMB, down from 285,714,534.98 RMB at the end of Q3 2023, a decrease of approximately 56.2%[20] - Cash inflow from financing activities in Q3 2024 was 223,700,000.00 RMB, compared to 290,000,000.00 RMB in Q3 2023, reflecting a decrease of approximately 22.7%[20] - The net cash flow from financing activities for Q3 2024 was -129,181,955.98 RMB, compared to -17,642,720.03 RMB in Q3 2023, indicating a worsening cash flow situation[20] - The company recorded a cash outflow of 352,881,955.98 RMB from financing activities in Q3 2024, up from 307,642,720.03 RMB in Q3 2023[20] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,567,749,643.85, a decrease of 12.77% from the end of the previous year[3] - The total assets decreased to CNY 1,567,749,643.85 in Q3 2024 from CNY 1,797,289,168.52 in Q3 2023, a decline of 12.8%[15] - Total liabilities decreased to CNY 755,936,674.05 in Q3 2024 from CNY 951,788,500.73 in Q3 2023, a reduction of 20.6%[15] - The company's total equity decreased to CNY 811,812,969.80 in Q3 2024 from CNY 845,500,667.79 in Q3 2023, a decline of 4.0%[15] Shareholder Information - The top shareholder, Shanghai Fengxian Investment (Group) Co., Ltd., holds 128.34 million shares, representing 18.74% of the total shares[10] - The second-largest shareholder, Shanghai Shangke Technology Investment Co., Ltd., holds 69.21 million shares, accounting for 10.11%[10] - The company has not reported any significant changes in shareholder relationships or actions among the top ten shareholders during the reporting period[11] Operational Insights - The decline in net profit was primarily due to reduced profits from subsidiaries Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. and Shanghai Zhonghe Software Co., Ltd.[8] - The company reported a significant decrease in cash received from sales and services compared to the previous year, impacting cash flow from operating activities[8] - Research and development expenses for the first three quarters of 2024 amounted to CNY 24,950,046.73, slightly down from CNY 26,969,495.02 in 2023[17] - The company has made adjustments to prior financial reports due to accounting errors, which were disclosed in April 2024[4] - Non-recurring gains and losses for the current period amounted to ¥1,877,533.74, with government subsidies contributing ¥2,505,859.56[6] Inventory and Receivables - Total current assets decreased from 1,064.72 million RMB at the end of 2023 to 857.89 million RMB as of September 30, 2024, representing a decline of approximately 19.4%[13] - Accounts receivable decreased slightly from 76.99 million RMB to 75.14 million RMB, indicating a reduction of about 2.4%[13] - Inventory decreased from 636.85 million RMB to 609.76 million RMB, a decline of approximately 4.3%[13] - Long-term equity investments increased from 24.61 million RMB to 24.91 million RMB, reflecting a growth of about 1.2%[13]